Patients across the UK are gaining faster access to new medicines thanks to a reformed US-UK drug pricing agreement that's already delivering results.

The government's refreshed pricing arrangements with pharmaceutical partners have opened doors for innovative treatments to reach NHS patients more quickly than ever before. This breakthrough follows years of negotiation and represents a significant shift in how medicines are valued and made available to the public. Read the full story →

Today's takeaway: When healthcare systems and industry work together on fair terms, everyone wins—especially patients waiting for life-changing treatments.